Multi-stakeholder workshop focused on the knowledge gaps that need to be filled, in order for us to be ready to design and implement prevention trials among pre-symptomatic C9orf72 carriers when promising therapeutic candidates emerge.
Co-organized with Dr. Adam Boxer (UCSF), and aimed to unify the ALS and FTD communities to plan for future C9orf72 prevention trials.
Podcast:
Recent Comments